Healthcare & Healthcare Services

Healthcare finance, from the operator's seat.

Reimbursement complexity, payor and provider economics, and regulated-business reporting are where I have spent my career, not a vertical I am exploring. CFO advisory for founder-led and PE-backed healthcare companies that need finance to lead.

$95M
Sale of Medicx Health to OptimizeRx (NASDAQ: OPRX), October 2023
$15–40M
Revenue scaled from a declining base through stabilization and growth
20%+
EBITDA margin, built from break-even post-stabilization
25+
Years in operating finance across healthcare, PBM, tech, and services
The Edge

Healthcare breaks generalist finance.

Healthcare revenue does not behave like a normal P&L. Reimbursement lags, contractual allowances, payor mix, and regulatory overhead all sit between billed revenue and collected cash. A finance leader who has not operated inside that complexity tends to manage the income statement and get surprised by the balance sheet... usually at the worst possible moment, when cash gets tight or a buyer starts asking about the quality of earnings.

The work I do is built on having run finance through exactly those conditions. I joined Medicx Health, a healthcare data and engagement business, when it had three months of cash on hand. We stabilized it in 90 days, scaled revenue from a declining base to $40M at 20%-plus EBITDA margins, and sold it to OptimizeRx (NASDAQ: OPRX) for $95M in October 2023. That arc... stabilize, scale, exit... is the same foundation every engagement runs on.

Three months of cash to a $95M exit. The healthcare-specific work was not a complication along the way. It was the job.

Where I focus

Engagements span the lifecycle, but the highest-leverage healthcare work tends to cluster in a few places:

  • Cash and reimbursement timing. Building visibility into the gap between billed, allowed, and collected, so liquidity decisions are made on real numbers.
  • Margin and EBITDA discipline. Separating durable margin from one-time or reimbursement-driven noise, especially under PE ownership where EBITDA expansion is the mandate.
  • Unit economics and pricing. Per-member, per-encounter, or per-contract economics that hold up to scrutiny from sophisticated payors and buyers.
  • Board and investor reporting. Moving board packages from backward-looking accounting summaries to forward-looking operating tools.
  • Transaction and exit readiness. Quality-of-earnings preparation, contract durability, and customer concentration work done before diligence, not during it.

Who I work with

Founder-led and PE-backed healthcare and healthcare-services companies, generally $5M to $100M in revenue, where the CEO needs a strategic finance partner rather than another controller or bookkeeper. That includes tech-enabled services, data and engagement businesses, provider and provider-adjacent groups, and insurance and benefits-related companies.

The typical trigger is a moment of pressure or opportunity: revenue has outrun the finance infrastructure, a capital raise or recapitalization is on the table, a turnaround is underway, or an exit is 24 to 60 months out and the financial story is not yet ready to survive diligence.

Starting smaller

If the scope is not yet clear, or the company is earlier than a full retainer warrants, the Pulse Check is the right entry point. Thirty days, a fixed fee, and a structured read on cash, margin, and KPI maturity ending in a prioritized action memo. It is built for the moment when a founder knows something is off but cannot yet name it.

Common Questions

Answers before the call.

The questions that come up first when a founder or sponsor is sizing up the fit.

What kinds of healthcare companies do you work with?+
Founder-led and PE-backed healthcare and healthcare-services businesses, generally $5M to $100M in revenue. That includes tech-enabled services, data and engagement companies, provider-adjacent groups, and insurance and benefits-related businesses.
Do you have direct healthcare operating experience?+
Yes. I led finance at Medicx Health, a healthcare data and engagement business, from three months of cash on hand through stabilization, scaling to $40M revenue at 20%-plus EBITDA, and a $95M sale to OptimizeRx in 2023.
How is this different from hiring a full-time healthcare CFO?+
You get senior, healthcare-literate strategic finance leadership at a fraction of the cost of a full-time hire, with no equity dilution, no search timeline, and no severance exposure. It fits companies that need CFO-grade thinking but cannot yet justify a full-time seat.
Can you help with a healthcare turnaround?+
Yes. Stabilizing a business under cash, margin, or covenant pressure is a core part of the work. The first 90 days are typically about cash visibility and stabilization before any growth or exit work begins.
What if I am not sure what I need yet?+
Start with a Pulse Check: a fixed-fee, 30-day diagnostic on cash, margin, and KPI maturity that ends in a prioritized action memo and a recommendation. It is the lowest-risk way to get a senior read before committing to a larger engagement.
Next Step

See where finance can take the business.

One direct conversation about the company's cash, margin, and what is on the horizon. That is usually enough to know whether this is the right partnership.